- Home
- GROV vs LVTX Comparison
GROV vs LVTX Comparison
Compare GROV & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- LVTX
- Stock Information
- Founded
- GROV 2016
- LVTX 2016
- Country
- GROV United States
- LVTX Netherlands
- Employees
- GROV N/A
- LVTX N/A
- Industry
- GROV Package Goods/Cosmetics
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- LVTX Health Care
- Exchange
- GROV Nasdaq
- LVTX Nasdaq
- Market Cap
- GROV 51.9M
- LVTX 43.9M
- IPO Year
- GROV N/A
- LVTX 2021
- Fundamental
- Price
- GROV $1.29
- LVTX $1.65
- Analyst Decision
- GROV Buy
- LVTX Strong Buy
- Analyst Count
- GROV 1
- LVTX 2
- Target Price
- GROV $2.00
- LVTX $6.00
- AVG Volume (30 Days)
- GROV 173.4K
- LVTX 34.6K
- Earning Date
- GROV 11-07-2024
- LVTX 11-14-2024
- Dividend Yield
- GROV N/A
- LVTX N/A
- EPS Growth
- GROV N/A
- LVTX N/A
- EPS
- GROV N/A
- LVTX N/A
- Revenue
- GROV $227,251,000.00
- LVTX $7,398,000.00
- Revenue This Year
- GROV N/A
- LVTX N/A
- Revenue Next Year
- GROV $5.97
- LVTX N/A
- P/E Ratio
- GROV N/A
- LVTX N/A
- Revenue Growth
- GROV N/A
- LVTX N/A
- 52 Week Low
- GROV $1.19
- LVTX $1.13
- 52 Week High
- GROV $2.49
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- GROV 45.73
- LVTX 46.15
- Support Level
- GROV $1.26
- LVTX $1.59
- Resistance Level
- GROV $1.33
- LVTX $1.75
- Average True Range (ATR)
- GROV 0.09
- LVTX 0.08
- MACD
- GROV -0.00
- LVTX 0.00
- Stochastic Oscillator
- GROV 21.43
- LVTX 41.18
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.